Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... brings CTT to the forefront in meeting the needs of patients in distress and improving palliative healthcare globally." RF|Binder will be leading an online and traditional ... Technologies, Inc. (NYSE Amex: CTT) to help roll out and promote it's Calmare Therapy Treatment*, an FDA-approved, non-invasive pain management medical device for treating ...
2009 NOV 9 ... 10 years. Purine analogs and monoclonal antibodies have enabled the shift from purely palliative treatment to intensive regimens aiming at complete remissions and possible prolongation ... 4RN United Kingdom. Keywords: Czech Republic, Chronic Lymphocytic Leukemia Therapy, Antimetabolite, Antineoplastic, Biotechnology, Cell Transplantation, Chlorambucil, ...
2009 NOV 9 ... hormonal treatment or biological therapy approved for the treatment of cancer; or palliative treatment or radiotherapy administered according to local practice. ...
2009 NOV 16 ... research from South Korea, "Self-expandable metal stents (SEMSs) are an effective palliative treatment for malignant biliary or duodenal Strictures, but endoscopic stenting for ... Duodenal Obstruction, Endoscopy, Gastroenterology, Gastrointestinal Endoscopy, Surgery, Therapy, Treatment. This article was prepared by Biotech Business Week editors from ...
2009 NOV 2 ... with lung cancer are less likely to be treated with either curative, or life-extending, palliative therapy." "Few elderly-specific phase III trials are available to provide level I ...
2009 NOV 23 ... Eighteen pet dogs with appendicular osteosarcoma received one 8 Gy fraction of palliative radiation on day 0. Force plate measurements and clinical assessments were made on days ... "A standard of therapy for osteosarcoma includes amputation with or without adjuvant chemotherapy. There is a ...
2009 NOV 16 ... cancer and endometriosis) and Q-Octreotide (primary indications in acromegaly, and palliative care). Q-Leuprolide and Q-Octreotide are three- and one-month sustained release ... Palliative Care, Pharmaceuticals, Prostate Cancer, Prostatic Neoplasms, Therapies, Therapy, Treatment, Women's Health, Business News. This article was prepared by ...
2009 NOV 16 ... fistula." Shinjo and colleagues published their study in the Journal of Palliative Medicine (Treatment of Malignant Enterovesical Fistula with Octreotide. Journal of ... Octreotide, Oncology, Palliative Care, Pharmaceuticals, Rectal Cancer, Rectal Carcinoma, Therapy, Treatment, Urinary Tract. This article was prepared by Biotech Business ...
2009 NOV 23 ... "We evaluated the response of 38 dogs treated with a coarsely fractionated, palliative radiation protocol based on CT-based 3D treatment planning. Dogs with histologically ... published their study in Veterinary Radiology & Ultrasound (3D CONFORMAL RADIATION THERAPY FOR PALLIATIVE TREATMENT OF CANINE NASAL TUMORS. Veterinary Radiology & Ultrasound, ...
2009 NOV 2 ... describe their etiologies and manifestations, and prescribe preventive and palliative therapy for their proper management. Estimates of the incidence of each complication also are ...
2009 NOV 2 ... 12 (24.5%) received definitive chemoradiotherapy (dCRT), and 22 (44.9%) received palliative treatment. Survival in patients with EDFE was significantly shorter (median and 2-year ... EDFE type (p=0.192). Two-year survival after oesophagectomy with or without neoadjuvant therapy was 45% in patients with EDFE compared with 42% in patients without EDFE (p=0.668)," ...
2009 NOV 9 ... even after adjustment for multiple prognostic factors and after excluding patients on palliative approach. There was no evidence of effect modification by age in any analyses," wrote ... Toronto, Life Sciences, Health Policy, Legislation, Clinical Trial Research, Treatment, Therapy, University of Toronto. This article was prepared by Biotech Business Week ...
2009 NOV 2 ... from Campbelltown, Australia, "A review of deceased oncology patients treated with palliative intent from April 2005 over 2 years at two cancer centres was carried out. Chi-square ... For additional information, contact D. Adams, Campbelltown Hospital, Macarthur Cancer Therapy Center, POB 149, Campbelltown, NSW 2560, Australia. The publisher of the ...
2009 NOV 10 ... to intensive care. Of the 8222 patients remaining under active treatment (patients under palliative care were excluded), there were 455 (5.5%) adverse events (431 intensive care unit ... Calgary, Life Sciences, Adverse Drug Event, Adverse Drug Effect, Adverse Drug Reaction, Therapy, Treatment, Clinical Trial Research, Palliative Care, Critical Care, Critical Care ...
2009 NOV 2 ... to cause HPVG. A 75-year-old man, diagnosed with metastatic NSCLC, was treated with palliative chemotherapy consisting of paclitaxel, carboplatin, and bevacizumab for six cycles. He ... United States report. "Bevacizumab has emerged as an effective standard therapy in the frontline management of advanced non-small cell lung cancer (NSCLC). Although ...
2009 NOV 16 ... "Palliative sedation is commonly used to treat refractory symptoms. A systematic review of guideline ... that sedation relieves symptoms because assessment of response is limited by the therapy. However, patient awareness during surgery occurs in 2%-3% of individuals of which the ...
2009 NOV 1 ... necessitated a major rethink in the preoperative preparation and management from simple palliative care to active directed intervention. This is particularly evident in the approach to ... Nutritional Research, Organ Transplant, Palliative Care, Pediatric, Pediatrics, Therapy, Transplantation, Treatment. This article was prepared by Pharma ...
2009 NOV 16 ... population demographics in developed societies will drive an increasing demand for palliative treatments associated with an aging patient base, explains George Perros, Greystone ... of drug therapies for chronic conditions such as pain management and hormone replacement therapy." A new report that presents a comprehensive assessment of the current ...
